Skip to main content

Table 1 Demographics of the study cohort

From: Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

 

Control (n = 59)

AD (n = 90)

Age, years, mean ± SD

78.5 ± 10.1

78.5 ± 9.7

Sex, F/M

22/37

55/35

PM delay, h, mean ± SD)

43.8 ± 36.4

45.2 ± 25.1

  1. AD Alzheimer’s disease, PM Post-mortem